ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

ClinicalTrials.gov ID: NCT00809146

Public ClinicalTrials.gov record NCT00809146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics

Study identification

NCT ID
NCT00809146
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Robert Silbergleit
Other
Enrollment
1,023 participants

Conditions and interventions

Interventions

  • Intramuscular route of active treatment Drug
  • Intravenous route of active treatment Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Dec 31, 2010
Completion
Dec 31, 2010
Last update posted
Jun 16, 2016

2009 – 2011

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
15
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85742
Stanford University Palo Alto California 94304-5777
University of California-San Francisco San Francisco California 94110
Emory University Atlanta Georgia 30303
University of Kentucky Lexington Kentucky 40536-0298
University of Maryland Baltimore Maryland 21201
Henry Ford Health System Detroit Michigan 48202
Wayne State University Detroit Michigan 48202
University of Minnesota Minneapolis Minnesota 55414
New York Presbyterian Hospital New York New York 10032
University of Cincinnati Medical Center Cincinnati Ohio 45267
Oregon Health and Science University Portland Oregon 97239-3098
University of Pennsylvania/York Philadelphia Pennsylvania 19104
Temple University-Main Line Philadelphia Pennsylvania 19140
University of Texas-Houston Houston Texas 77030
Virginia Commonwealth University Richmond Virginia 23298
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00809146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2016 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00809146 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →